ROTH is hosting its 33rd Annual Roth Conference virtually this year, from March 15-17. Featured at the event under the Pharmaceuticals/Medical technology umbrella will be 1-on-1/small group meetings for institutional investors, an industry panel and numerous virtual fireside chats.
Details on the Panel:
Flipping the Switch to Profitability Panel – March 16 at 10:00 AM
Description: This panel will highlight three companies in ROTH’s Medical Technologies coverage universe (IRIX, SRTS, CSBR) that are approaching or becoming cash flow positive. ROTH is holding this panel as a forum where investors can get to know these three companies better.
- Iridex Corporation (IRIX) David Bruce, CEO
- Sensus Healthcare Inc (SRTS) Joe Sardano, CEO
- Champions Oncology, Inc (CSBR) David Miller, CFO
Monday, March 15
- 11:30 – 11:55 AM – Ligand Pharmaceuticals, Inc (LGND)
- 4:30 – 4:55 PM – InMed Pharmaceuticals Inc (INM)
- 5:00 – 5:25 PM – Assertio Therapeutics, Inc (ASRT)
Tuesday, March 17
- 11:00 – 11:25 AM – Fortress Biotech, Inc (FBIO)
- 11:30 – 11:55 AM – Vivos Therapeutics, Inc (VVOS)
ROTH also has 1×1 meetings available with the following companies under its coverage:
- Assertio Therapeutics, Inc (ASRT)
- Beyond Air, Inc (XAIR)
- BioDelivery Sciences International, Inc. (BDSI)
- Catalyst Pharmaceuticals, Inc (CPRX)
- Champions Oncology, Inc (CSBR)
- Delcath Systems, Inc (DCTH)
- Fortress Biotech, Inc (FBIO)
- InMed Pharmaceuticals Inc (INM)
- Intec Pharma Ltd (NTEC)
- INVO Bioscience, Inc (INVO)
- IRadimed Corporation (IRMD)
- Iridex Corporation (IRIX)
- Lannett Company (LCI)
- LeMaitre Vascular (LMAT)
- Ligand Pharmaceuticals Inc (LGND)
- Myomo, Inc (MYO)
- RedHill Biopharma Ltd (RDHL)
- Sensus Healthcare, Inc (SRTS)
- Soliton, Inc (SOLY)
- Viking Therapeutics, Inc (VKTX)
- Vivos Therapeutics, Inc (VVOS)
- Zynerba Pharmaceuticals, Inc (ZYNE)
For more information on this year’s event, visit https://ibn.fm/nkr8O
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.